Bionano Genomics, Inc. 2026 Q1 - Results - Earnings Call Presentation
Bionano Genomics Inc BNGO
$1.23
โผ -0.81%
($-0.01)
Open
$1.24
Prev Close
$1.24
Day Range
$1.21 โ $1.26
52W Range
$1.06 โ $5.50
Market Cap
$14.33M
Beta
1.65
EPS (TTM)
$-5.14
๐ Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2018-08-01 |
| Shares Out. | 11,470,000 |
| Website | bionano.com/ โ |
| Phone | 13026587581 |
Bionano Genomics Inc is a publicly traded company under the ticker symbol BNGO on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
๐ Analyst Ratings
9 analysts (2026-05-01)
๐ฐ Latest News for BNGO
Bionano Genomics, Inc. (BNGO) Q1 2026 Earnings Call Transcript
Transcript : Bionano Genomics, Inc., Q1 2026 Earnings Call, May 13, 2026
Transcript: Bionano Genomics Q1 2026 Earnings Conference Call
Bionano Genomics Q1 EPS $(0.76) Beats $(0.95) Estimate, Sales $6.687M Beat $6.567M Estimate
Bionano Genomics Sees Q2 Sales $7.500M-$7.800M vs $7.520M Est
Bionano Genomics Affirms FY2026 Sales Guidance of $30.000M-$33.000M vs $32.137M Est
Bionano Reports First Quarter 2026 Results and Provides a Business Update
